Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-08-14 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
公司章程（2020年8月修订）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of 金宇生物技术股份有限公司, revised in August 2020. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, financial accounting, profit distribution, auditing, shareholder meetings, voting procedures, and other governance-related rules. There is no indication that this is a financial report, earnings release, or announcement of voting results. Instead, it is a governance document outlining the internal rules and governance practices of the company. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2020-08-14 Chinese
2020年限制性股票激励计划实施考核管理办法
Governance Information Classification · 95% confidence The document is titled '2020 年限制性股票激励计划实施考核管理办法' which translates to '2020 Restricted Stock Incentive Plan Implementation Assessment Management Measures'. It details the assessment and management procedures for a stock incentive plan, including governance, assessment principles, scope, responsibilities, assessment system, process, and application of results. There is no financial data, earnings, or regulatory filing information. It is a governance-related document focused on internal incentive plan management rather than a financial report or announcement. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. The closest specific category is Governance Information (CGR), which covers internal rules and governance practices. The document is not an announcement or a short notice but a detailed policy document, supporting classification as CGR with high confidence.
2020-08-14 Chinese
经世律师事务所关于金宇生物技术股份有限公司2020年限制性股票激励计划之法律意见书
Regulatory Filings
2020-08-14 Chinese
2020年半年度募集资金存放与实际使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the management and actual use of funds raised by the company through a non-public stock issuance. It includes specifics on the amount raised, usage to date, storage, and compliance with regulatory requirements. The document references regulatory guidelines from the China Securities Regulatory Commission and Shanghai Stock Exchange related to the management and use of raised funds. It also includes financial figures on the use of the raised capital for the half-year period ending June 30, 2020. The document is titled as a "专项报告" (special report) on the use of raised funds for the 2020 half-year period, which aligns with a capital/financing update rather than a full annual or interim financial report. It is not an earnings release, annual report, or audit report, but a specific update on fundraising capital usage. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (5825 characters) and content confirm it is a substantive report, not just an announcement or certification, so it is not RPA or RNS.
2020-08-14 Chinese
第十届监事会第六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of a company regarding the approval of the 2020 semi-annual report, a special report on the use of raised funds, and stock incentive plans. It includes voting results and compliance statements but does not contain the full semi-annual report or detailed financial statements itself. The document is relatively short (1529 characters) and serves as an official announcement of meeting decisions and approvals rather than the report itself. Therefore, it fits best as a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2020-08-14 Chinese
关于变更经营范围的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a change in the business scope of the company, including details of the revised business activities and authorization for management to handle related registration procedures. It is a regulatory announcement about operational changes, not a financial report, meeting material, or voting result. The document is short (723 characters) and does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-08-14 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.